Novo Nordisk A/S
$47.18
-8.58%(-4.43)
▼Why is $NVO Down Today?
$NVO is down 8.58% today. Check the latest news below for potential catalysts.
For educational purposes only
30-Day Price History
AlphaFeed Signal History
Full tracker →US-listed shares of Novo Nordisk jumped 3% after the Danish drugmaker announced a partnership with OpenAI to accelerate AI-driven drug discovery. The deal expands pharma's AI buildout and pairs a GLP-1 giant with the leading AI lab.
Risk: Partnership may lack near-term revenue impact; market could fade hype quickly.
Latest News
Why Is BioAge Labs Stock Sinking Friday?
Benzinga
Novo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients
Benzinga
Novo Nordisk Announces Ziltivekimab Did Not Translate Into Major Adverse Cardiovascular Events Risk Reduction During Phase 3 Trial In Patients With Atherosclerotic Cardiovascular Disease
Benzinga
Novo Nordisk: Too Late For A Great Opportunity
SeekingAlpha
4 Health Care Stocks With Whale Alerts In Today’s Session
Benzinga
Key Stats
Track this ticker
AlphaFeed HQ content is for educational purposes only. This is not financial advice. Do not buy, sell, or hold any security based on this content. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. AlphaFeed HQ is not a registered investment advisor. For educational purposes only.